HeartBeam completes enrollment ahead of schedule in 486-patient heart attack detection study
BEAT•HeartBeam completed enrollment ahead of schedule in its 486-patient HEADSTART-ACS study in Jakarta, which evaluates its system for detecting acute coronary syndrome. Data analysis is underway, with results expected at a 2027 cardiology conference; the system is not currently cleared for heart attack detection.
1. Study enrollment completed
HeartBeam completed enrollment ahead of schedule in the 486-patient HEADSTART-ACS study at the National Cardiovascular Center Harapan Kita in Jakarta, Indonesia. The study evaluates the system’s ability to detect acute coronary syndrome, including heart attacks, against standard ECG testing and discharge diagnoses.
2. Other study milestones
Data analysis is underway, with results expected to be presented at a cardiology conference in 2027. Combined enrollment in HEADSTART-ACS and the 132-patient ALIGN-ACS pilot is above 600 patients; ALIGN-ACS results are slated for presentation at TCT 2026. A pivotal U.S. study is planned for the first quarter of 2027, and the system is not currently cleared for heart attack detection.
